25 Jun 2020 --- NattoPharma is partnering with KD Nutra – a KD Pharma Group company – to develop a new ingredient for cardiovascular (CV) health. The product will combine KD Nutra’s KD-PüR high concentrate omega 3s with NattoPharma’s vitamin K2, called MenaQ7 PharmaPure MK-7. This comes as NattoPharma amps up its calls for an established Recommended Daily Intake (RDI) for vitamin K2. Research partners from the Norway-based company have published a paper identifying the specific activity of the vitamin.
